| Paremyd (U.S.N.L.M.) | ||
|---|---|---|
| Dosing | 1 or 2 drops in the conjunctival sac. | |
| Chem Specs | hydroxyamphetamine 1% / tropicamide 0.25% | |
| Quantities | 15ml | |
| Cost | 110.00/15ml | |
| Class | Indirectly-acting sympathomimetic. / Parasympatholytic (acetylcholine receptor blocker.) | |
| Action | HYDROXYAMPHETAMINE causes release of norepinephrine at the nerve terminal. TROPICAMIDE blocks iris sphincter and the ciliary body response. |
|
| Usage | Indicated for mydriasis in routine diagnostic procedures. Provides mydriasis with partial cycloplegia. Slightly less dilation than tropicamide 1% with phenylephrine 2.5% |
|
| Onset - 15min. Max about 40 - 60min. Recovery in 6-8 hrs. (24hrs occasionally). | ||
| Contraindications | Primary glaucoma, narrow anterior chamber angle, hypersensitivity to any component of the product. |
|
| Pediatric use | May rarely cause dangerous CNS disturbances. Psychotic reactions, behavioral disturbances, and vasomotor or cardiorespiratory collapse in children have been reported with the use of anticholinergic drugs. |
|
| Pregnancy | Category C. Animal reproduction studies have not been conducted with PAREMYD®. | |